Hacker News Reader

Now, how to prevent the attempts of big pharma to patent these to make tens of thousand of Indians/Africans pay big $$. These AI modelers are reputedly not validly a human creation = patent/copyright. These protein constructs might have a long room temp shelf life = needed in most Indian/African bite victims.

View on HN

These will probably be ignored rather than patented/monopolized by Big Pharma. A few million treatable cases per year globally, concentrated in low-income countries, is a small market to chase. Medical needs in low-income countries need to be addressed by governments or nonprofits rather than for-profit companies.

EDIT: replaced "100,000 treatable cases" with "a few million treatable cases" per https://pmc.ncbi.nlm.nih.gov/articles/PMC11020954/ referenced by Lol_arco.

One hopes a storable and long lasting product will be able to save many of those 100,000 deaths(??), but you are correct - it might not offer enough $$ to USA pharma?

Yeah there isn't enough money in it for big pharma. Maybe some other form of funding, but this is the reason why all these tropical diseases are neglected.

Reply on news.ycombinator.com